
Results
11
Companies which are potentially undervalued and in an acceptable financial position.
11 companies
Otsuka Holdings
Market Cap: JP¥5.4t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,210.00
7D
-3.5%
1Y
40.8%
Kissei Pharmaceutical
Market Cap: JP¥160.6b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,910.00
7D
2.9%
1Y
-6.5%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,781.50
7D
-2.9%
1Y
11.9%
Sumitomo Pharma
Market Cap: JP¥610.3b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,370.00
7D
-4.7%
1Y
29.5%
Astellas Pharma
Market Cap: JP¥3.8t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,139.50
7D
-1.0%
1Y
54.1%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,204.00
7D
-0.9%
1Y
41.2%
Daiichi Sankyo Company
Market Cap: JP¥4.5t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,507.50
7D
0.7%
1Y
-28.7%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,450.00
7D
-1.4%
1Y
-0.09%
Santen Pharmaceutical
Market Cap: JP¥622.6b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,916.00
7D
-0.6%
1Y
13.4%
Tsumura
Market Cap: JP¥279.1b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,722.00
7D
1.1%
1Y
10.3%
PeptiDream
Market Cap: JP¥122.9b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥933.70
7D
-9.4%
1Y
-43.8%